Example: bankruptcy
WHEN AND HOW TO PRESCRIBE STATINS
a. Moderate-intensity statin I A b. Consider high-intensity statin when ≥7.5% 10-y ASCVD risk using the Pooled Cohort Equations † IIa B 4. Primary prevention—No diabetes 40–75 years of age and LDL-C 70–189 mg/dL a. Estimate 10-y ASCVD risk using the Risk Calculator based on the Pooled Cohort
Tags:
Information
Domain:
Source:
Link to this page:
Related documents
Table 5. Statin Dose Intensity and Equivalency Chart*
www.mqic.orgStatin Dose Intensity and Equivalency Chart* ... Rosuvastatin Atorvastatin Pitavastatin Simvastatin Lovastatin Pravastatin Fluvastatin High-Intensity (lowers LDL-C ≥ 50%) 63 40 mg ($196) 62 61 60 80mg ($9 gen, $ 236. br) 59 58 56 20 mg 54 ($196) 52 10 mg ($196) 50 40mg ($9 gen, $ 236. br) Moderate-Intensity (lowers LDL-C 30% to < 50%) br) 48 ...
Lipids
www.moh.gov.sgof high intensity statins for individuals at the highest risk of coronary artery disease, and the roles of non-statin lipid lowering therapies has been clarified through a ... risk in adults recommended moderate intensity statin therapy, e.g. simvastatin 20-40 mg or its equivalent
High and Moderate- Intensity Statin Table
www.pharmacyquality.comHigh-intensity statin therapy Moderate-intensity statin therapy Prescription Rosuvastatin 20-40 mg Simvastatin 80 mg Ezetimbe-simvastatin 80 mg Sitagliptin-simvastatin 20-40 mg Pravastatin 40—80 mg Lovastatln 40 mg Niacin-lovastatin 40 mg Fluvastatin XL 80 mg Fluvastatin 40 mg bid Pitavastatin 2—4 mg Atorvastatln 40—80 mg
Simplified lipid guidelines
www.cfp.ca-Any statin intensity is preferred to non-statin lipid-lowering therapy (moderate-level evidence).-Alternate daily dosing can be considered if a patient does not tolerate daily dosing (low-level evidence).-In patients who have severe reactions like rhabdomyolysis, retrial might not be appropriate (low-level evidence).
Statin Prescribing - Gloucestershire Hospitals NHS ...
www.gloshospitals.nhs.ukInitiate with a lower dose and avoid very high dose or high intensity statins if at increased risk of myotoxicity e.g. the elderly, severe renal impairment (eGFR<30), liver impairment, undertreated hypothyroidism, high alcohol intake, history of previous statin or muscle toxicity, trauma/major surgery, and concomitant medications (see page 5